✦ LIBER ✦

Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

✍ Scribed by Tan, Jing; Zhou, Jingguo; Zhao, Pan; Wei, Jing

Book ID: 118791282
Publisher: Springer
Year: 2012
Tongue: English
Weight: 164 KB
Volume: 31
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-012-1988-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of nonbiologic disease-modifying ant

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

✍ Lacaille, Diane ;Guh, Daphne P. ;Abrahamowicz, Michal ;Anis, Aslam H. ;Esdaile, 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Newer disease-modifying antirheumatic dr

Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis

✍ Samy Suissa; Pierre Ernst; Marie Hudson; Alain Bitton; Abbas Kezouh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Effects of disease-modifying antirheumat

Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population-based cohort study

✍ Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 150 KB

Etanercept in combination with conventio

Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate

✍ Yoshinobu Koyama; Hirokazu Shiraishi; Toshiyuki Ohta; Ayumi Uchino 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 350 KB

Cost effectiveness of adding leflunomide

Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

✍ Maetzel, Andreas ;Strand, Vibeke ;Tugwell, Peter ;Wells, George ;Bombardier, Cla 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Efficacy of roxithromycin in adult patie

Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial

✍ Mesut Ogrendik 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 234 KB